DY has shed 15% in a week and 18% over the past month, closing at $351.80 after what appears to be a punishing post-earnings reaction — the tension now is whether the analyst community's lofty targets, clustered well above current prices, reflect a real recovery thesis or simply haven't caught up with the new reality.
The options market has shifted decisively since the pre-earnings note filed three days ago. Before the print, the put/call ratio sat at 0.59, deeply call-heavy. It has since climbed back toward the 20-day average, settling at 0.68 — still below the 0.77 mean but no longer the aggressive bull lean that characterised the setup into results. The z-score reads -0.86, meaning positioning is modestly more call-favoured than average, but the rotation away from the pre-earnings call skew is visible in the data. Options traders hedged up after the stock broke lower; the protection trade came too late for most.
Short positioning tells a notably different story from the price action. Short interest actually fell sharply this week — dropping roughly 13% to 4.5% of the free float, its lowest level in several weeks. That's a meaningful cover, not a pile-on. The borrow market remains extremely loose: availability is running at nearly 2,000% of outstanding short interest, meaning there are roughly 28.6 million shares available to lend against 1.3 million currently borrowed. Cost to borrow is 0.40% — elevated by about 60% versus last week's level, but still negligible in absolute terms. The short score has eased to 38.3, down from around 41 earlier in the month, consistent with the covering activity. Positioning looks opportunistic rather than aggressive — some shorts took profits into the sell-off rather than pressing the position.
The Street remains broadly bullish, but the gap between consensus and price has become conspicuous. Analyst targets from late May — when JP Morgan, Wells Fargo, and Cantor Fitzgerald all raised targets to the $650 area after the prior quarter's results — now sit roughly 80% above the current price. That is a wide gulf. Given those moves were reported around May 28 and the consensus mean registers at $637, and given the stock has since fallen sharply, these targets are materially stale relative to where the stock trades today at $351.80. No recent analyst actions are visible in the data, so the Street's response to today's print remains to be seen. Factor scores offer modest colour: the 90-day EPS momentum rank sits at a strong 91st percentile, suggesting estimate revisions have been positive over a longer horizon, even as the 30-day reading is more middling at 44. The short score rank of 31 and DTC rank of 34 confirm that short-side pressure is below average for the stock's history.
Institutional holders appear reasonably anchored. Peconic Partners remains the largest disclosed holder at nearly 15% of shares. First Trust added roughly 110,000 shares and Raymond James added around 133,000 in the most recent reporting period ending June 30 — both meaningful additions made at prices that now look elevated relative to today. BlackRock and Vanguard have made only minor adjustments. The insider data is stale — the last reported trades are from late March, when the CEO, CFO, and General Counsel all sold shares at $341.96 as part of what appears to be a scheduled award-and-sell cycle. Those prices are close to where the stock trades today, which will not be lost on investors assessing whether management saw the current level as fair value at the time.
Earnings history provides limited comfort. The two prior prints with available reaction data both produced negative first-day moves: -3.5% after the August 2026 Q2 print and -3.6% after May 2026 results, with the May print extending to a -7.7% five-day loss. The current week's decline is larger in magnitude than either of those prior reactions. Closest peers moved in a similar direction: MTZ fell 12% on the week and MYRG lost 8.6%, while AMRC dropped 13% — suggesting some of DY's weakness reflects sector-wide pressure rather than an entirely company-specific verdict. The next scheduled earnings event is November 18, which means the stock now faces a long period without a near-term catalyst to force a re-rating in either direction.
What to watch next is whether sell-side analysts reset targets materially lower in the days following today's print — the size of any downward revisions will determine whether the current price represents a genuine discount to the Street's updated view or simply the first leg of a prolonged de-rating.
See the live data behind this article on ORTEX.
Open DY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
